AstraZeneca PLCAZN:NYQ

2.240 / 3.24%
Close in USDToday's changeShares traded1 year changeBeta
As of Apr 22 2014 21:01 BST.Data delayed by at least 15 minutes.


On Tuesday, AstraZeneca PLC (AZN:NYQ) closed at 66.86, 4.01% below its 52-week high of 69.65, set on Apr 21, 2014.

52-week range
Jun 24 2013
Apr 21 2014
Markit short selling activity
Day high--
Day low--
Previous close66.86
Average volume3.35m
Shares outstanding1.26bn
Free float1.24bn
P/E (TTM)32.80
Market cap83.86bn USD
Annual div (TTM)3.80 USD
Annual div yield (TTM)5.50%
Div ex-dateFeb 19 2014
Div pay-dateMar 24 2014

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AstraZeneca PLC+6.94%+4.24%+28.85%+30.36%+100.18%
S&P 500 INDEX+1.98%+0.70%+7.12%+20.29%+122.81%
As of Apr 22 2014 21:01 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.